IMPACT STORY 2
Pre-Launch Readiness and Health Technology Assessment
“How do we build a credible, compelling case for value – navigating speed to access, complexity, evidence and engagement gaps?”
A new therapy approached launch without aligned value narratives or HTA preparedness across global and local teams.
A focused HTA strategy and core value dossier were developed leveraging proprietary approaches to see through complexity and rapidly tailor payer materials to bridge regulatory, clinical, and access perspectives.
The Result
Strategic alignment, confident stakeholder engagement, and a clear roadmap to navigate HTA submissions and secure optimal pricing and reimbursement access.
Linked Service Line
Early Access Strategy / HTA Preparedness
Linked Disease Area
Immunology
Linked Product Lifecycle Stage
Late-stage Development / Pre-Launch